Amgen
Search results
Regeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need. Learn more.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Founded and led for 35 years by physician-scientists, Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Learn more.
Regeneron is a leading biotechnology company using the power of science to bring new medicines to patients in need. Explore Regeneron's global presence.
Discover how Regeneron helps people with serious diseases by exploring our FDA-approved medicines, industrial operations, investigational pipeline and more.
Find addresses and contact information for Regeneron's offices in North America, Europe and Asia. Our antibody combination is not currently authorized for use in any U.S. region. Please refer to the authorized Fact Sheet and FDA statement for additional details.
Monitor SARS-CoV-2 variants with Regeneron’s COVID-19 Dashboard. Refreshed daily with new genomes and associated patient metadata. Learn how Regeneron is actively working on testing existing medicines and developing new antibodies to combat the COVID-19 pandemic.
